Geriatric COVID-19 Serology

NCT05109546 | Unknown

• 1 other identifier: 8438
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

Coronaviruses are important human and animal pathogens. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in China's Hubei province. It quickly spread, leading to an epidemic across China, followed by an increasing number of cases in other countries around the world. In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019. The virus that causes COVID-19 is SARS-CoV-2. The duration of protection during which a patient after infection and / or vaccination remains clinically protected and the evolution of their serology as well as their titre remains unknown

Conditions

COVID-19

Keywords

COVID-19; SARS-COV-2; Elderly people; Geriatric; RT-PCR SARS-CoV-2

Outcome Measures

Primary Outcomes (1)

• Retrospective study of COVID serologies in a geriatric population after infection or vaccination

  Files analysed retrospectively from July 1, 2020 to November 30, 2021 will be examined]

Eligibility Criteria

• Age: 76 Years+
• Sex: all
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patient hospitalized or resident in the geriatrics center from July 1, 2020 to November 30, 2021 having presented with COVID or having benefited from a COVID vaccination.

You may qualify if:

• Age\> 75 years old
• Patient hospitalized or resident in the geriatrics center from July 1, 2020 to November 30, 2021 having presented with COVID or having benefited from a COVID vaccination.
• Subject not having expressed their opposition, after information, to the reuse of their data for the purposes of this research

You may not qualify if:

• Subject having expressed opposition to participating in the study
• Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, etc.)
• Subject under guardianship, curatorship or safeguard of justice

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service SSR Gériatrique - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Maxence MEYER, MD

  Service SSR Gériatrique - Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Maxence MEYER, MD

CONTACT

33 3 88 11 56 16; maxence.meyer@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

said.chayer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 4, 2021
• First Posted: November 5, 2021
• Study Start: October 15, 2021
• Primary Completion: March 1, 2022
• Study Completion: March 31, 2022
• Last Updated: November 17, 2021

Record last verified: 2021-11

Locations

FR (1)